Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients

Barbara Banelli, Stefano Bonassi, Ida Casciano, Katia Mazzocco, Angela Di Vinci, Paola Scaruffi, Claudio Brigati, Giorgio Allemanni, Luana Borzì, Gian Paolo Tonini, Massimo Romani

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients'. Together they form a unique fingerprint.

Medicine & Life Sciences